Sentinal4D

Pre-Seed
sentinal4d.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Pre-Seed
Last Announced Dec 19, 2024
Investors Undisclosed
Decision Makers 2 Available

About Sentinal4D

At Sentinal4D, we believe patients battling cancer, neurodegenerative diseases, and chronic inflammatory syndromes deserve personalized therapeutics. We are deploying a biology-first, holistic approach with focus on phenotypic-based drug discovery.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Pre-Seed
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website sentinal4d.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised undisclosed · Pre-Seed

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Sentinal4D.

Funding History

1 Round
Pre-Seed equity · Dec 19, 2024

Founders & Leadership

2

Chris Bakal

CEO & CO-FOUNDER

Work email & phone locked Unlock →

Matt De Vries

CTO & CO-FOUNDER

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts